Purpose: Malignant peripheral nerve sheath tumor (MPNST) can arise sporadically or in association with neurofibromatosis type 1. Deletions at the 9p21 locus have been reported in these tumors. To additionally characterize the status of this chromosomal region, in this study we performed a comprehensive, mostly PCR-based molecular analysis of the three tumor suppressor genes p15 INK4b, p14ARF and p16INK4a located at the 9p21 locus in 26 cryo-preserved MPNSTs. Experimental Design: Fourteen neurofibromatosis type 1-related and 12 sporadic cases were investigated for homozygous deletion coupled with fluorescent in situ hybridization, promoter methylation, and mutational analysis, as well as m-RNA expression. Results: The results showed that an ...
Malignant peripheral nerve sheath tumors (MPNSTs) are sarcomas of Schwann cell lineage origin that o...
Neurofibromatosis Type I (NF1) is an autosomal dominant disorder characterized by the development of...
Abstract Background Malignant peripheral nerve sheath tumors (MPNSTs) are rare and highly aggressive...
Karyotypic complexities associated with frequent loss or rearrangement of a number of chromosome arm...
The molecular biology underlying the development of highly malignant peripheral nerve sheath tumors ...
Purpose: Neurofibromatosis type 1 (NF1) is an autosomal dominant condition that predisposes to benig...
About 10% of neurofibromatosis type 1 (NF1) patients develop malignant peripheral nerve sheath tumor...
PURPOSE: The purpose of this study was to identify genetic aberrations contributing to clinical aggr...
PurposeThe purpose of this study was to identify genetic aberrations contributing to clinical aggres...
Objective Neurofibromatosis type 1 (NF1) patients have a 13% risk of developing a malignant perip...
The commonest tumors associated with neurofibromatosis type 1 (NF1) are benign peripheral nerve shea...
Neurofibromatosis type 1 (NF1) patients are at increased risk of developing both benign (neurofibrom...
Malignant peripheral nerve sheath tumor is a rare and aggressive disease with poor treatment respons...
Malignant peripheral nerve sheath tumors (MPNSTs) are sarcomas of Schwann cell lineage origin that o...
Neurofibromatosis Type I (NF1) is an autosomal dominant disorder characterized by the development of...
Abstract Background Malignant peripheral nerve sheath tumors (MPNSTs) are rare and highly aggressive...
Karyotypic complexities associated with frequent loss or rearrangement of a number of chromosome arm...
The molecular biology underlying the development of highly malignant peripheral nerve sheath tumors ...
Purpose: Neurofibromatosis type 1 (NF1) is an autosomal dominant condition that predisposes to benig...
About 10% of neurofibromatosis type 1 (NF1) patients develop malignant peripheral nerve sheath tumor...
PURPOSE: The purpose of this study was to identify genetic aberrations contributing to clinical aggr...
PurposeThe purpose of this study was to identify genetic aberrations contributing to clinical aggres...
Objective Neurofibromatosis type 1 (NF1) patients have a 13% risk of developing a malignant perip...
The commonest tumors associated with neurofibromatosis type 1 (NF1) are benign peripheral nerve shea...
Neurofibromatosis type 1 (NF1) patients are at increased risk of developing both benign (neurofibrom...
Malignant peripheral nerve sheath tumor is a rare and aggressive disease with poor treatment respons...
Malignant peripheral nerve sheath tumors (MPNSTs) are sarcomas of Schwann cell lineage origin that o...
Neurofibromatosis Type I (NF1) is an autosomal dominant disorder characterized by the development of...
Abstract Background Malignant peripheral nerve sheath tumors (MPNSTs) are rare and highly aggressive...